HPV Vaccine Communication: Special considerations for a unique vaccine. (WHO/IVB/13.12)
back to documentsThis report presents communication guidance and specific considerations for countries that plan to introduce human papillomavirus (HPV) vaccine into their national immunization programme. New vaccine introduction is a hallmark of the Decade of Vaccines, but HPV vaccine is unique for many reasons. This report aims to offer guidance in two main areas: The first is to offer advice on basic communication planning and implementation for immunization; the second is to discuss specific considerations for HPV vaccine.
Also available in: French